Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Orlinger KK"'
Autor:
Boopathy AV; Clinical Virology, Gilead Sciences, Inc., Foster, California, USA., Nekkalapudi A; Clinical Virology, Gilead Sciences, Inc., Foster, California, USA., Sung J; Drug Metabolism, Gilead Sciences, Inc., Foster, California, USA., Schulha S; Virology, Hookipa Pharma Inc., New York, New York, USA., Jin D; Protein Therapeutics, Gilead Sciences, Inc., Foster, California, USA., Sharma B; Discovery Virology, Gilead Sciences, Inc., Foster, California, USA., Ng S; Oncology, Gilead Sciences, Inc., Foster, California, USA., Lu S; Protein Therapeutics, Gilead Sciences, Inc., Foster, California, USA., Wimmer R; Virology, Hookipa Pharma Inc., New York, New York, USA., Suthram S; Bioinformatics, Gilead Sciences, Inc., Foster, California, USA., Ahmadi-Erber S; Virology, Hookipa Pharma Inc., New York, New York, USA., Lauterbach H; Global Research and Development, Hookipa Pharma Inc., New York, New York, USA., Orlinger KK; Global Research and Development, Hookipa Pharma Inc., New York, New York, USA., Hung M; Protein Therapeutics, Gilead Sciences, Inc., Foster, California, USA., Carr B; Drug Metabolism, Gilead Sciences, Inc., Foster, California, USA., Callebaut C; Clinical Virology, Gilead Sciences, Inc., Foster, California, USA., Geleziunas R; Clinical Virology, Gilead Sciences, Inc., Foster, California, USA., Kuhne M; Oncology, Gilead Sciences, Inc., Foster, California, USA., Schmidt S; Virology, Hookipa Pharma Inc., New York, New York, USA., Falkard B; Clinical Virology, Gilead Sciences, Inc., Foster, California, USA.
Publikováno v:
Journal of virology [J Virol] 2024 Jul 23; Vol. 98 (7), pp. e0029424. Date of Electronic Publication: 2024 Jun 03.
Autor:
Raguz J; Hookipa Pharma Inc, New York, NY, USA., Pinto C; Hookipa Pharma Inc, New York, NY, USA., Pölzlbauer T; Hookipa Pharma Inc, New York, NY, USA., Habbeddine M; Hookipa Pharma Inc, New York, NY, USA., Rosskopf S; Hookipa Pharma Inc, New York, NY, USA., Strauß J; Hookipa Pharma Inc, New York, NY, USA., Just V; Hookipa Pharma Inc, New York, NY, USA., Schmidt S; Hookipa Pharma Inc, New York, NY, USA., Bidet Huang K; Hookipa Pharma Inc, New York, NY, USA., Stemeseder F; Hookipa Pharma Inc, New York, NY, USA., Schippers T; Hookipa Pharma Inc, New York, NY, USA., Stewart E; Vienna BioCenter Core Facilities GmbH (VBCF), Vienna, Austria., Jez J; Vienna BioCenter Core Facilities GmbH (VBCF), Vienna, Austria., Berraondo P; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain., Orlinger KK; Hookipa Pharma Inc, New York, NY, USA., Lauterbach H; Hookipa Pharma Inc, New York, NY, USA Henning.Lauterbach@hookipapharma.com.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2024 Apr 17; Vol. 12 (4). Date of Electronic Publication: 2024 Apr 17.
Autor:
Gomar C; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain., Di Trani CA; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain., Bella A; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain., Arrizabalaga L; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain., Gonzalez-Gomariz J; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain., Fernandez-Sendin M; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain., Alvarez M; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain., Russo-Cabrera JS; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain., Ardaiz N; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain., Aranda F; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain., Schippers T; Hookipa Pharma Inc, New York, New York, USA., Quintero M; Highlight Therapeutics, Valencia, Spain., Melero I; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.; Departments of Immunology and Oncology, Clínica Universidad de Navarra, Pamplona, Spain., Orlinger KK; Hookipa Pharma Inc, New York, New York, USA., Lauterbach H; Hookipa Pharma Inc, New York, New York, USA., Berraondo P; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain pberraondol@unav.es.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2024 Apr 16; Vol. 12 (4). Date of Electronic Publication: 2024 Apr 16.
Autor:
Purde MT; Institute of Immunobiology, Kantonsspital St. Gallen, 9007 St. Gallen, Switzerland., Cupovic J; Institute of Immunobiology, Kantonsspital St. Gallen, 9007 St. Gallen, Switzerland., Palmowski YA; Department of Pathology and Neuropathology, University Hospital and Comprehensive Cancer Center Tübingen, 72076 Tübingen, Germany., Makky A; Department of Pathology and Neuropathology, University Hospital and Comprehensive Cancer Center Tübingen, 72076 Tübingen, Germany., Schmidt S; Hookipa Pharma Inc., New York, NY 10118, USA., Rochwarger A; Department of Pathology and Neuropathology, University Hospital and Comprehensive Cancer Center Tübingen, 72076 Tübingen, Germany., Hartmann F; Institute of Immunobiology, Kantonsspital St. Gallen, 9007 St. Gallen, Switzerland., Stemeseder F; Hookipa Pharma Inc., New York, NY 10118, USA., Lercher A; Research Center for Molecular Medicine (CeMM) of the Austrian Academy of Sciences, 1090 Vienna, Austria., Abdou MT; Institute of Immunobiology, Kantonsspital St. Gallen, 9007 St. Gallen, Switzerland., Bomze D; Institute of Immunobiology, Kantonsspital St. Gallen, 9007 St. Gallen, Switzerland., Besse L; Laboratory of Experimental Oncology, Department of Oncology and Hematology, Kantonsspital St. Gallen, 9007 St. Gallen, Switzerland., Berner F; Institute of Immunobiology, Kantonsspital St. Gallen, 9007 St. Gallen, Switzerland., Tüting T; Laboratory of Experimental Dermatology, Department of Dermatology, University Hospital Magdeburg, 39120 Magdeburg, Germany., Hölzel M; Institute of Experimental Oncology, University Hospital Bonn, 53127 Bonn, Germany., Bergthaler A; Research Center for Molecular Medicine (CeMM) of the Austrian Academy of Sciences, 1090 Vienna, Austria., Kochanek S; Department of Gene Therapy, Ulm University, 89081 Ulm, Germany., Ludewig B; Institute of Immunobiology, Kantonsspital St. Gallen, 9007 St. Gallen, Switzerland., Lauterbach H; Hookipa Pharma Inc., New York, NY 10118, USA., Orlinger KK; Hookipa Pharma Inc., New York, NY 10118, USA., Bald T; QIMR Medical Research Institute, Herston, QLD 4006, Australia., Schietinger A; Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Schürch C; Department of Pathology and Neuropathology, University Hospital and Comprehensive Cancer Center Tübingen, 72076 Tübingen, Germany., Ring SS; Institute of Immunobiology, Kantonsspital St. Gallen, 9007 St. Gallen, Switzerland., Flatz L; Institute of Immunobiology, Kantonsspital St. Gallen, 9007 St. Gallen, Switzerland; Department of Dermatology, Kantonsspital St. Gallen, 9007 St. Gallen, Switzerland. Electronic address: lukas.flatz@med.uni-tuebingen.de.
Publikováno v:
Molecular therapy : the journal of the American Society of Gene Therapy [Mol Ther] 2024 Feb 07; Vol. 32 (2), pp. 426-439. Date of Electronic Publication: 2023 Dec 05.
Autor:
Schwendinger M; Hookipa Pharma Inc., New York, New York, USA., Thiry G; Hookipa Pharma Inc., New York, New York, USA.; Senergues Consult, Saint Etienne de Maurs, France., De Vos B; Bejamad bvba, Consultancy Office Pharmaceutical Sciences, Dworp, Belgium., Leroux-Roels G; Center for Vaccinology (CEVAC), Ghent University Hospital, Ghent, Belgium., Bruhwyler J; ECSOR, Brussels, Belgium., Huygens A; Caprion Biosciences, Gosselies, Belgium., Ganeff C; Caprion Biosciences, Gosselies, Belgium., Buchinger H; Hookipa Pharma Inc., New York, New York, USA., Orlinger KK; Hookipa Pharma Inc., New York, New York, USA., Pinschewer DD; Hookipa Pharma Inc., New York, New York, USA.; University of Basel, Department of Biomedicine - Haus Petersplatz, Basel, Switzerland., Monath TP; Hookipa Pharma Inc., New York, New York, USA.; Crozet BioPharma LLC, Devens, Massachusetts, USA., Lilja AE; Hookipa Pharma Inc., New York, New York, USA.
Publikováno v:
The Journal of infectious diseases [J Infect Dis] 2022 Apr 19; Vol. 225 (8), pp. 1399-1410.
Autor:
Lauterbach H; Hookipa Pharma Inc., New York, NY, United States., Schmidt S; Hookipa Pharma Inc., New York, NY, United States., Katchar K; Hookipa Pharma Inc., New York, NY, United States., Qing X; Hookipa Pharma Inc., New York, NY, United States., Iacobucci C; Hookipa Pharma Inc., New York, NY, United States., Hwang A; Hookipa Pharma Inc., New York, NY, United States., Schlienger K; Hookipa Pharma Inc., New York, NY, United States., Berka U; Hookipa Pharma Inc., New York, NY, United States., Raguz J; Hookipa Pharma Inc., New York, NY, United States., Ahmadi-Erber S; Hookipa Pharma Inc., New York, NY, United States., Schippers T; Hookipa Pharma Inc., New York, NY, United States., Stemeseder F; Hookipa Pharma Inc., New York, NY, United States., Pinschewer DD; Department of Biomedicine - Haus Petersplatz, Division of Experimental Virology, University of Basel, Basel, Switzerland., Matushansky I; Hookipa Pharma Inc., New York, NY, United States., Orlinger KK; Hookipa Pharma Inc., New York, NY, United States.
Publikováno v:
Frontiers in oncology [Front Oncol] 2021 Oct 14; Vol. 11, pp. 732166. Date of Electronic Publication: 2021 Oct 14 (Print Publication: 2021).
Autor:
Ring SS; Institute of Immunobiology, Kantonsspital St.Gallen, St.Gallen, Switzerland., Cupovic J; Institute of Immunobiology, Kantonsspital St.Gallen, St.Gallen, Switzerland.; Max Planck Institute of Immunology and Epigenetics, Freiburg, Germany., Onder L; Institute of Immunobiology, Kantonsspital St.Gallen, St.Gallen, Switzerland., Lütge M; Institute of Immunobiology, Kantonsspital St.Gallen, St.Gallen, Switzerland., Perez-Shibayama C; Institute of Immunobiology, Kantonsspital St.Gallen, St.Gallen, Switzerland., Gil-Cruz C; Institute of Immunobiology, Kantonsspital St.Gallen, St.Gallen, Switzerland., Scandella E; Institute of Immunobiology, Kantonsspital St.Gallen, St.Gallen, Switzerland., De Martin A; Institute of Immunobiology, Kantonsspital St.Gallen, St.Gallen, Switzerland., Mörbe U; Institute of Immunobiology, Kantonsspital St.Gallen, St.Gallen, Switzerland., Hartmann F; Institute of Immunobiology, Kantonsspital St.Gallen, St.Gallen, Switzerland., Wenger R; Department of Plastic Reconstructive Surgery, Kantonsspital St. Gallen, St. Gallen, Switzerland., Spiegl M; Department of Plastic Reconstructive Surgery, Kantonsspital St. Gallen, St. Gallen, Switzerland., Besse A; Department of Medical Oncology and Hematology, Kantonsspital St.Gallen, St.Gallen, Switzerland., Bonilla WV; Division of Experimental Virology, Department of Biomedicine, University of Basel, Basel, Switzerland., Stemeseder F; Hookipa Pharma Inc., New York, USA., Schmidt S; Hookipa Pharma Inc., New York, USA., Orlinger KK; Hookipa Pharma Inc., New York, USA., Krebs P; Institute of Pathology, University of Berne, Berne, Switzerland., Ludewig B; Institute of Immunobiology, Kantonsspital St.Gallen, St.Gallen, Switzerland. burkhard.ludewig@kssg.ch.; Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland. burkhard.ludewig@kssg.ch., Flatz L; Institute of Immunobiology, Kantonsspital St.Gallen, St.Gallen, Switzerland. lukas.flatz@kssg.ch.; Department of Dermatology, Kantonsspital St. Gallen, St. Gallen, Switzerland. lukas.flatz@kssg.ch.; Department of Dermatology, University Hospital Zurich, Zurich, Switzerland. lukas.flatz@kssg.ch.
Publikováno v:
Nature communications [Nat Commun] 2021 Aug 05; Vol. 12 (1), pp. 4734. Date of Electronic Publication: 2021 Aug 05.
Autor:
Bonilla WV; University of Basel, Department of Biomedicine, Basel, Switzerland., Kirchhammer N; University of Basel, Department of Biomedicine, Basel, Switzerland., Marx AF; University of Basel, Department of Biomedicine, Basel, Switzerland., Kallert SM; University of Basel, Department of Biomedicine, Basel, Switzerland., Krzyzaniak MA; University of Basel, Department of Biomedicine, Basel, Switzerland., Lu M; University of Basel, Department of Biomedicine, Basel, Switzerland., Darbre S; Department of Pathology and Immunology, University of Geneva, Geneva, Switzerland., Schmidt S; Hookipa Pharma Inc., Vienna, Austria., Raguz J; Hookipa Pharma Inc., Vienna, Austria., Berka U; Hookipa Pharma Inc., Vienna, Austria., Vincenti I; Department of Pathology and Immunology, University of Geneva, Geneva, Switzerland., Pauzuolis M; Department of Pathology and Immunology, University of Geneva, Geneva, Switzerland., Kerber R; Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany., Hoepner S; Tumor Immunology, Department for BioMedical Research, University of Bern, Bern, Switzerland., Günther S; Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany., Magnus C; Institute of Virology, University of Zurich, Zurich, Switzerland., Merkler D; Department of Pathology and Immunology, University of Geneva, Geneva, Switzerland.; Division of Clinical Pathology, University Hospitals of Geneva, Geneva, Switzerland., Orlinger KK; Hookipa Pharma Inc., Vienna, Austria., Zippelius A; University of Basel, Department of Biomedicine, Basel, Switzerland.; Medical Oncology, University Hospital Basel, Basel, Switzerland., Pinschewer DD; University of Basel, Department of Biomedicine, Basel, Switzerland.
Publikováno v:
Cell reports. Medicine [Cell Rep Med] 2021 Mar 03; Vol. 2 (3), pp. 100209. Date of Electronic Publication: 2021 Mar 03 (Print Publication: 2021).
Autor:
Schmidt S; Hookipa Pharma Inc., New York, NY, USA., Bonilla WV; Department of Biomedicine - Haus Petersplatz, Petersplatz 10, Division of Experimental Virology, University of Basel, Basel, Switzerland., Reiter A; Hookipa Pharma Inc., New York, NY, USA., Stemeseder F; Hookipa Pharma Inc., New York, NY, USA., Kleissner T; Hookipa Pharma Inc., New York, NY, USA., Oeler D; Hookipa Pharma Inc., New York, NY, USA., Berka U; Hookipa Pharma Inc., New York, NY, USA., El-Gazzar A; Hookipa Pharma Inc., New York, NY, USA., Kiefmann B; Hookipa Pharma Inc., New York, NY, USA., Schulha SC; Hookipa Pharma Inc., New York, NY, USA., Raguz J; Hookipa Pharma Inc., New York, NY, USA., Habbeddine M; Hookipa Pharma Inc., New York, NY, USA., Scheinost M; Hookipa Pharma Inc., New York, NY, USA., Qing X; Hookipa Pharma Inc., New York, NY, USA., Lauterbach H; Hookipa Pharma Inc., New York, NY, USA., Matushansky I; Hookipa Pharma Inc., New York, NY, USA., Pinschewer DD; Department of Biomedicine - Haus Petersplatz, Petersplatz 10, Division of Experimental Virology, University of Basel, Basel, Switzerland., Orlinger KK; Hookipa Pharma Inc., New York, NY, USA.
Publikováno v:
Oncoimmunology [Oncoimmunology] 2020 Sep 15; Vol. 9 (1), pp. 1809960. Date of Electronic Publication: 2020 Sep 15.
Autor:
Schleiss MR; Center for Infectious Diseases and Microbiology Translational Research and Department of Pediatrics, University of Minnesota Medical School, Minneapolis, Minnesota, USA schleiss@umn.edu., Berka U; Hookipa Biotech AG, Vienna, Austria., Watson E; Hookipa Biotech AG, Vienna, Austria., Aistleithner M; Hookipa Biotech AG, Vienna, Austria., Kiefmann B; Hookipa Biotech AG, Vienna, Austria., Mangeat B; Department of Pathology and Immunology, University of Geneva, Geneva, Switzerland., Swanson EC; Center for Infectious Diseases and Microbiology Translational Research and Department of Pediatrics, University of Minnesota Medical School, Minneapolis, Minnesota, USA., Gillis PA; Center for Infectious Diseases and Microbiology Translational Research and Department of Pediatrics, University of Minnesota Medical School, Minneapolis, Minnesota, USA., Hernandez-Alvarado N; Center for Infectious Diseases and Microbiology Translational Research and Department of Pediatrics, University of Minnesota Medical School, Minneapolis, Minnesota, USA., Fernández-Alarcón C; Center for Infectious Diseases and Microbiology Translational Research and Department of Pediatrics, University of Minnesota Medical School, Minneapolis, Minnesota, USA., Zabeli JC; Center for Infectious Diseases and Microbiology Translational Research and Department of Pediatrics, University of Minnesota Medical School, Minneapolis, Minnesota, USA., Pinschewer DD; Department of Pathology and Immunology, University of Geneva, Geneva, Switzerland., Lilja AE; Hookipa Biotech AG, Vienna, Austria., Schwendinger M; Hookipa Biotech AG, Vienna, Austria., Guirakhoo F; Hookipa Biotech AG, Vienna, Austria., Monath TP; Hookipa Biotech AG, Vienna, Austria., Orlinger KK; Hookipa Biotech AG, Vienna, Austria.
Publikováno v:
Clinical and vaccine immunology : CVI [Clin Vaccine Immunol] 2017 Jan 05; Vol. 24 (1). Date of Electronic Publication: 2017 Jan 05 (Print Publication: 2017).